142 related articles for article (PubMed ID: 21542297)
1. [CYP2D6 genotypes and phenotypes in Chinese Han, Uygur and Kazakh populations].
Li GC; Yang J; Zhou T; Chen ZG; Chen W
Yao Xue Xue Bao; 2011 Feb; 46(2):238-42. PubMed ID: 21542297
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.
Li D; Zhang GL; Lou YQ; Li Q; Wang X; Bu XY
J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792
[TBL] [Abstract][Full Text] [Related]
3. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.
Yin SJ; Ni YB; Wang SM; Wang X; Lou YQ; Zhang GL
J Clin Pharm Ther; 2012 Jun; 37(3):364-9. PubMed ID: 21913948
[TBL] [Abstract][Full Text] [Related]
4. Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population.
Cai WM; Chen B; Zhang WX
Clin Pharmacol Ther; 2007 Jan; 81(1):95-8. PubMed ID: 17186005
[TBL] [Abstract][Full Text] [Related]
5. Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations.
Wang SM; Zhu AP; Li D; Wang Z; Zhang P; Zhang GL
J Hum Genet; 2009 Jun; 54(6):372-5. PubMed ID: 19444287
[TBL] [Abstract][Full Text] [Related]
6. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.
Zuo LJ; Guo T; Xia DY; Jia LH
Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic polymorphisms of eNOS and CYP2D6 in mainland Chinese Tibetan, Mongolian, Uygur, and Han populations.
Qi G; Yin S; Zhang G; Wang X
Pharmacogenomics J; 2020 Feb; 20(1):114-125. PubMed ID: 31616043
[TBL] [Abstract][Full Text] [Related]
8. Ethnic disparities in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study.
Li N; Wang H; Yan Z; Yao X; Hong J; Zhou L
BMC Public Health; 2012 Jul; 12():499. PubMed ID: 22759741
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians.
Droll K; Bruce-Mensah K; Otton SV; Gaedigk A; Sellers EM; Tyndale RF
Pharmacogenetics; 1998 Aug; 8(4):325-33. PubMed ID: 9731719
[TBL] [Abstract][Full Text] [Related]
10. Distribution of
Abudukeremu M; Ayoufu A; Tuerhong A; Paizula X; Ou JH
Open Life Sci; 2024; 19(1):20220728. PubMed ID: 38681733
[TBL] [Abstract][Full Text] [Related]
11. Relationship between EPHX2 gene polymorphisms and essential hypertension in Uygur, Kazakh, and Han.
Zhu XL; Wang L; Wang Z; Chen SZ; Zhang WQ; Ma MM
Genet Mol Res; 2015 Apr; 14(2):3474-80. PubMed ID: 25966114
[TBL] [Abstract][Full Text] [Related]
12. A common missense single nucleotide polymorphism in the E-selectin gene is significantly associated with essential hypertension in the Han population but only weakly associated in the Uygur population.
Wang Z; Xu Y; Chen S; Wang L; Ding H; Lu G; Wang D; Zhai Z; Duan J; Zhang W
Hypertens Res; 2012 Apr; 35(4):413-7. PubMed ID: 22158116
[TBL] [Abstract][Full Text] [Related]
13. Effects of the Chinese herbal formula "Zuojin Pill" on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype.
Qiu F; Liu S; Miao P; Zeng J; Zhu L; Zhao T; Ye Y; Jiang J
Eur J Clin Pharmacol; 2016 Jun; 72(6):689-95. PubMed ID: 27023460
[TBL] [Abstract][Full Text] [Related]
14. Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population.
Kiyotani K; Shimizu M; Kumai T; Kamataki T; Kobayashi S; Yamazaki H
Eur J Clin Pharmacol; 2010 Oct; 66(10):1065-8. PubMed ID: 20700584
[TBL] [Abstract][Full Text] [Related]
15. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.
Qi GZ; Zhang ZY; Wang X; Yin SJ; Lou YQ; Zhang GL
J Clin Pharm Ther; 2016 Feb; 41(1):84-91. PubMed ID: 26763760
[TBL] [Abstract][Full Text] [Related]
16. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.
Kubota T; Yamaura Y; Ohkawa N; Hara H; Chiba K
Br J Clin Pharmacol; 2000 Jul; 50(1):31-4. PubMed ID: 10886115
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population.
Tateishi T; Chida M; Ariyoshi N; Mizorogi Y; Kamataki T; Kobayashi S
Clin Pharmacol Ther; 1999 May; 65(5):570-5. PubMed ID: 10340923
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
Zuo J; Xia D; Jia L; Guo T
Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
[TBL] [Abstract][Full Text] [Related]
19. CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.
Byeon JY; Kim YH; Lee CM; Kim SH; Chae WK; Jung EH; Choi CI; Jang CG; Lee SY; Bae JW; Lee YJ
Arch Pharm Res; 2018 Sep; 41(9):921-930. PubMed ID: 30191460
[TBL] [Abstract][Full Text] [Related]
20. [Comparative research on the relationship between body mass index and physical fitness index among the Uygur, Kazakh and Han ethnic college students].
Li W; Tuerdi Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):411-417. PubMed ID: 38864125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
